Drug Trial Radar · NCT03235479
Safety and Efficacy Study in Adult Subjects With Acute Migraines
Last checked: Nov 19, 2026Latest source record: Feb 16, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,485
Actual
Start
Jul 18, 2017
Primary completion
Jan 21, 2018
Study completion Jan 26, 2018
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 1, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines
Conditions
- Migraine, With or Without Aura
Interventions
RimegepantDrug
75 mg tablet QD
PlaceboDrug
Placebo tablet to match rimegepant dose QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Freedom From Pain at 2 Hours Post-doseTime frame: 2 hours post-dose
- Percentage of Participants With Freedom From Most Bothersome Symptom (MBS) at 2 Hours Post-doseTime frame: 2 hours post-dose
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates, Inc
Birmingham, Alabama
Neurological Physicians of Arizona/Radiant Research Inc
Gilbert, Arizona
Clinical Research Consortium Arizona
Tempe, Arizona
Radiant Research, Inc.
Tucson, Arizona
Woodland International Research Group, LLC
Little Rock, Arkansas
Pharmacology Research Institute
Encino, California
Optimus Medical Group
San Francisco, California
California Medical Clinic for Headache
Santa Monica, California
Diablo Clinical Research, Inc
Walnut Creek, California
Qps Mra, Llc
Hollywood, Florida
Multi-Specialty Research Associates, Inc
Lake City, Florida
Qps Mra, Llc
Miami, Florida
Advanced Pharma CR, LLC
Miami, Florida
Compass Research, LLC
Orlando, Florida
Ormond Medical Arts Pharmaceutical Research
Ormond Beach, Florida
Meridian Clinical Research
Savannah, Georgia
New Orleans Center for Clinical Research
New Orleans, Louisiana
Boston Clinical Trials, Inc
Boston, Massachusetts
Milford Emergency Associates, Inc.
Marlborough, Massachusetts
Michigan Head Pain & Neurological Institute
Ann Arbor, Michigan
Clinical Research Institute, Inc
Minneapolis, Minnesota
Clinical Research Institute
Minneapolis, Minnesota
The Center for Pharmaceutical Research
Kansas City, Missouri
Sundance Clinical Research, LLC
St Louis, Missouri
Meridian Clinical Research -Norfolk
Norfolk, Nebraska
Meridian Clinical Research, LLC
Omaha, Nebraska
Clinical Research Consortium- Las Vegas
Las Vegas, Nevada
Hassman Research Institute, LLC
Berlin, New Jersey
SPRI Clinical Trials, LLC
Brooklyn, New York
Regional Clinical Research, Inc.
Endwell, New York
Central New York Clinical Research
Manlius, New York
Fieve Clinical Research
New York, New York
Rochester Clinical Research, Inc
Rochester, New York
PharmQuest, LLC
Greensboro, North Carolina
CTI Clinical Research Center
Cincinnati, Ohio
Oregon Center for Clinical Investigations, Inc
Portland, Oregon
Clinical Research of Philadelphia, LLC
Philadelphia, Pennsylvania
Preferred Primary Care Physicians
Uniontown, Pennsylvania
Omega Medical Research
Warwick, Rhode Island
Coastal Carolina Research Center
Mt. Pleasant, South Carolina
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.